for hims semaglutide glp-1 compound news Troubling Findings in Study of Compounders Inc Wegovy maker strikes deal with

Liraglutide treatment ameliorates neurotoxicity induced by stable silencing of Pin1

Have you noticed personality changes or depression since starting on GLP-1 drugs

Munaf M, Pellicori P, Allgar V, Wong K: A meta-analysis of the therapeutic effects of glucagon-like Peptide-1 agonist in heart failure

Modern GLP-1 receptor agonists have demonstrated average weight loss of 15-20% of body weight with sustained treatment, representing a breakthrough in obesity pharmacotherapy that approaches the effectiveness of bariatric surgery

Consult a physician before use if taking any medications or having any known medical condition

Zhang B, Cheng Z, Chen J et al (2024) Efficacy and safety of mazdutide in Chinese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial